Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 17/20 | 0.66 |
| ▸ | ADRB1 | P08588 | 11/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 10/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27647623 | 1.00 | ADRB3 (0.66) | ADRB3ADRB1ADRB2 | |
| Hydrochloric Acid SCHEMBL4582623 | 0.91 | ADRB3 (0.73) | ADRB3ADRB1ADRB2 | |
| Hydrochloric Acid SCHEMBL4471319 | 0.81 | ADRB3 (0.66) | ADRB3ADRB1ADRB2 | |
| Hydrochloric Acid SCHEMBL4471313 | 0.81 | ADRB3 (0.66) | ADRB3ADRB1ADRB2 | |
| SCHEMBL9830900 | 0.81 | ADRB1 (0.67) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7121360 | 0.80 | ADRB1 (0.66) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7124327 | 0.80 | ADRB1 (0.66) | ADRB3ADRB1ADRB2 | |
| SCHEMBL20819407 | 0.79 | ADRB1 (0.55) | ADRB3ADRB1ADRB2 | |
| SCHEMBL5703841 | 0.78 | CHRNA7 (0.57) | ADRB3ADRB1ADRB2 | |
| SCHEMBL11746227 | 0.78 | ADRB1 (0.54) | ADRB3ADRB1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100582088-C | Aminoalcohol derivatives | ASTELLAS PHARMA INC | 2010-01-20 | — | — | CN | disclosed |
| US-7417060-B2 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2008-08-26 | — | — | US | disclosed |
| CN-1906154-A | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 2007-01-31 | — | — | CN | disclosed |
| US-20050137236-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137236-A1 | Aminoalcohol derivatives | GPR39, PRMT9, CHRM2 | ADRB3 86/4885ADRB1 70/4885ADRB2 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.